Aryan Modasi1, Jerry T Dang2, Sadaf Afraz3, Joshua Hefler2, Noah Switzer2, Daniel W Birch4, Shahzeer Karmali4. 1. Department of Surgery, Royal Alexandra Hospital, University of Alberta, 10240 Kingsway NW, Edmonton, AB, T5H 3V9, Canada. aryan.modasi@medportal.ca. 2. Department of Surgery, Royal Alexandra Hospital, University of Alberta, 10240 Kingsway NW, Edmonton, AB, T5H 3V9, Canada. 3. Department of Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA. 4. Centre for Advancement of Surgical Education and Simulation (CASES), Royal Alexandra Hospital, Edmonton, Alberta, Canada.
Abstract
BACKGROUND: Obesity has been found to be an independent predictor of adverse cardiac and pulmonary embolic events. As the popularity of bariatric surgery grows, surgeons are encountering more patients taking therapeutic anticoagulation medications preoperatively. This study aims to assess the safety of bariatric surgery on these patients. METHODS: Data was extracted from 2015 to 2017 using the MBSAQIP database. Included patients were those who underwent a primary LSG or LRYGB. A multivariable regression analysis was performed looking at 30-day outcomes for pre-operatively anticoagulated patients. A secondary propensity-matched analysis was performed comparing outcomes among patients undergoing LSG vs LRYGB. RESULTS: A total of 430,396 patients were analyzed, 11,013 (2.56%) of which were taking anticoagulation medications pre-operatively. Absolute 30-day complication rates (8.73% vs 3.36%, p < 0.001), bleed rates (3.78% vs 0.88%, p < 0.001), leak rates (0.55% vs 0.41%, p = 0.021), cardiac event rates (0.43% vs 0.06%, p < 0.001), and venous thromboembolism rates (0.68% vs 0.25%, p < 0.001) were significantly higher among pre-operatively anticoagulated patients. On multivariable analysis, pre-operative anticoagulation was found to be an independent predictor of postoperative bleeding (OR 2.76, CI 2.43-3.14, p < 0.001) and mortality (OR 2.08, CI 1.49-2.90, p < 0.001). The LRYGB was associated with a significantly higher complication rate compared to the LSG (13.27% vs 7.40%, p < 0.001) in the propensity-matched cohorts. CONCLUSIONS: Patients undergoing bariatric surgery on anticoagulation medications pre-operatively are at a significantly higher risk of adverse outcomes post-operatively. Patients who require long-term anticoagulation should undergo careful consideration before proceeding with bariatric surgery.
BACKGROUND: Obesity has been found to be an independent predictor of adverse cardiac and pulmonary embolic events. As the popularity of bariatric surgery grows, surgeons are encountering more patients taking therapeutic anticoagulation medications preoperatively. This study aims to assess the safety of bariatric surgery on these patients. METHODS: Data was extracted from 2015 to 2017 using the MBSAQIP database. Included patients were those who underwent a primary LSG or LRYGB. A multivariable regression analysis was performed looking at 30-day outcomes for pre-operatively anticoagulated patients. A secondary propensity-matched analysis was performed comparing outcomes among patients undergoing LSG vs LRYGB. RESULTS: A total of 430,396 patients were analyzed, 11,013 (2.56%) of which were taking anticoagulation medications pre-operatively. Absolute 30-day complication rates (8.73% vs 3.36%, p < 0.001), bleed rates (3.78% vs 0.88%, p < 0.001), leak rates (0.55% vs 0.41%, p = 0.021), cardiac event rates (0.43% vs 0.06%, p < 0.001), and venous thromboembolism rates (0.68% vs 0.25%, p < 0.001) were significantly higher among pre-operatively anticoagulated patients. On multivariable analysis, pre-operative anticoagulation was found to be an independent predictor of postoperative bleeding (OR 2.76, CI 2.43-3.14, p < 0.001) and mortality (OR 2.08, CI 1.49-2.90, p < 0.001). The LRYGB was associated with a significantly higher complication rate compared to the LSG (13.27% vs 7.40%, p < 0.001) in the propensity-matched cohorts. CONCLUSIONS:Patients undergoing bariatric surgery on anticoagulation medications pre-operatively are at a significantly higher risk of adverse outcomes post-operatively. Patients who require long-term anticoagulation should undergo careful consideration before proceeding with bariatric surgery.
Authors: Sandhya B Kumar; Barbara C Hamilton; Stephanie G Wood; Stanley J Rogers; Jonathan T Carter; Matthew Y Lin Journal: Surg Obes Relat Dis Date: 2018-02-08 Impact factor: 4.734
Authors: Gautam Sharma; Zubaidah Nor Hanipah; Ali Aminian; Suriya Punchai; Emre Bucak; Philip R Schauer; Stacy A Brethauer Journal: Obes Surg Date: 2018-08 Impact factor: 4.129
Authors: Lars D Horvei; Sigrid K Brækkan; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; John-Bjarne Hansen Journal: Eur J Epidemiol Date: 2014-09-12 Impact factor: 8.082
Authors: Jerry T Dang; Noah Switzer; Megan Delisle; Michael Laffin; Richdeep Gill; Daniel W Birch; Shahzeer Karmali Journal: Surg Endosc Date: 2018-07-12 Impact factor: 4.584
Authors: Ramon Mourelo; Orit Kaidar-Person; Patricio Fajnwaks; Paul E Roa; David Pinto; Samuel Szomstein; Raul J Rosenthal Journal: Obes Surg Date: 2008-01-05 Impact factor: 4.129
Authors: Petter K Nyström; Axel C Carlsson; Karin Leander; Ulf de Faire; Mai-Lis Hellenius; Bruna Gigante Journal: PLoS One Date: 2015-05-15 Impact factor: 3.240
Authors: Hugo Meunier; Benjamin Menahem; Yannick Le Roux; Adrien Lee Bion; Yoann Marion; Antoine Vallois; Nicolas Contival; Thomas Gautier; Jean Lubrano; Anaïs Briant; Jean-Jacques Parienti; Arnaud Alves Journal: Obes Surg Date: 2021-04-28 Impact factor: 4.129